Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11333
Title: Bicarbonate in diabetic ketoacidosis - a systematic review.
Authors: Chua, Horng Ruey;Schneider, Antoine G;Bellomo, Rinaldo
Affiliation: Department of Intensive Care, Austin Health, Melbourne, Victoria, Australia. Rinaldo.BELLOMO@austin.org.au.
Issue Date: 6-Jul-2011
Citation: Annals of Intensive Care 2011; 1(1): 23
Abstract: This study was designed to examine the efficacy and risk of bicarbonate administration in the emergent treatment of severe acidemia in diabetic ketoacidosis (DKA).PUBMED database was used to identify potentially relevant articles in the pediatric and adult DKA populations. DKA intervention studies on bicarbonate administration versus no bicarbonate in the emergent therapy, acid-base studies, studies on risk association with cerebral edema, and related case reports, were selected for review. Two reviewers independently conducted data extraction and assessed the citation relevance for inclusion.From 508 potentially relevant articles, 44 were included in the systematic review, including three adult randomized controlled trials (RCT) on bicarbonate administration versus no bicarbonate in DKA. We observed a marked heterogeneity in pH threshold, concentration, amount, and timing for bicarbonate administration in various studies. Two RCTs demonstrated transient improvement in metabolic acidosis with bicarbonate treatment within the initial 2 hours. There was no evidence of improved glycemic control or clinical efficacy. There was retrospective evidence of increased risk for cerebral edema and prolonged hospitalization in children who received bicarbonate, and weak evidence of transient paradoxical worsening of ketosis, and increased need for potassium supplementation. No studies involved patients with an initial pH < 6.85.The evidence to date does not justify the administration of bicarbonate for the emergent treatment of DKA, especially in the pediatric population, in view of possible clinical harm and lack of sustained benefits.
Internal ID Number: 21906367
URI: http://ahro.austin.org.au/austinjspui/handle/1/11333
DOI: 10.1186/2110-5820-1-23
URL: http://www.ncbi.nlm.nih.gov/pubmed/21906367
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
File Description SizeFormat 
21906367.pdf254.57 kBAdobe PDFThumbnail
View/Open


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.